C. Dupont

发表

[Low vaccination coverage against influenza in elderly hospitalized in France].

A. Beauchet, G. Gavazzi, E. Rouveix, 2013, La Revue de medecine interne.

[Evaluation of amoxicillin-clavulanic acid prescriptions in a teaching hospital of Parisian suburb].

T. Hanslik, B. Heym, E. Rouveix, 2008, La Revue de medecine interne.

Asbjørn Mohr Drewes, Vitoantonio Bevilacqua, Roshan Cools, 2016 .

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

C. Rouzioux, S. Pol, H. Fontaine, 2006, AIDS.

Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004.

J. Desenclos, S. Pol, L. Gambotti, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Cobicistat-vinblastine interaction and severe peripheral neuropathy.

C. Dupont, S. Bauler, M. Venon, 2015, AIDS.

Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients

P. Aegerter, A. Beauchet, P. Saiag, 2000 .

Long-term ef®cacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients

E. Rouveix, C. Dupont, Philippe, 2022 .

Streptococcus pneumoniae vaccinal coverage in hospitalized elderly patients in France.

A. Beauchet, G. Gavazzi, E. Rouveix, 2013, Medecine et maladies infectieuses.

Microbiological findings about pulmonary cryptosporidiosis in two AIDS patients

M. Bougnoux, E. Rouveix, C. Dupont, 1996, Journal of clinical microbiology.

[To avoid complications, treatment of meningitis should follow the guidelines and be reevaluated at 48 hours].

E. Rouveix, C. Dupont, M. Chadenat, 2000 .

[Acquired angioneurotic edema: association with hydatidosis].

E. Rouveix, C. Dupont, M. Chadenat, 2000, Presse medicale.

Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy

D. Costagliola, C. Dhiver, M. Mary-Krause, 2006, AIDS.

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor

D. Costagliola, S. Grabar, P. Fabbro-Péray, 2000, AIDS.

Frequency, determinants and consequences of delayed access to care for HIV infection in France

E. Lanoy, D. Costagliola, M. Mary-Krause, 2007, Antiviral therapy.

ENDOCARDITE A CORYNEBACTERIUM DIPHTHERIAE TOLERANTE A L'AMOXICILLINE. REPONSE DE L'AUTEUR

E. Rouveix, C. Dupont, L. Turner, 1995 .

Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.

D. Costagliola, S. Grabar, C. Pradier, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Neuropsychology supervision: A survey of practices in Quebec and a cross-cultural comparison

N. Gosselin, B. Gauthier, C. Dupont, 2020, Clinical Neuropsychologist.

The Predictive Value of Head Circumference Growth during the First Year of Life on Child Traits in Early Childhood

C. Dupont, 2018 .

Trends in survival after cancer diagnosis among HIV‐infected individuals between 1992 and 2009. Results from the FHDH‐ANRS CO4 cohort

D. Costagliola, S. Grabar, J. Spano, 2015, International journal of cancer.

[Sulfasalazine neurotoxicity].

E. Rouveix, C. Dupont, M. Raffin-Sanson, 2001, Annales de medecine interne.

Impact of Newly Available Drugs on Clinical Progression in Patients with Virological Failure after Exposure to Three Classes of Antiretrovirals

D. Costagliola, C. Pradier, D. Salmon, 2005, Antiviral therapy.

Maraviroc Intensification in HIV-1 Infected Patients with Persistant Low-levelViremia

E. Rouveix, C. Dupont, D. Mathez, 2016 .

[Cushing's syndrome induced by combined treatment with inhaled fluticasone and oral ritonavir].

T. Chinet, E. Rouveix, V. Giraud, 2009, Revue des maladies respiratoires.

[A prospective study of antibiotic prescribing in an emergency care unit].

B. Heym, H. Goulet, E. Rouveix, 2009, Medecine et maladies infectieuses.

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

D. Benhamou, F. Brun-Vézinet, Y. Yazdanpanah, 2021, The Lancet.

The Predictive Value of Head Circumference Growth during the First Year of Life on Early Child Traits

G. Muckle, W. Fraser, J. Séguin, 2018, Scientific Reports.

With a Multidrug-Resistant

E. Rouveix, C. Dupont, M. Chadenat, 2016 .

Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.

P. Aegerter, A. Beauchet, P. Saiag, 2000, AIDS.

Primary infection with a multidrug-resistant HIV-1 strain.

E. Rouveix, C. Dupont, M. Chadenat, 2001, Archives of internal medicine.

Medical and social differences between French and migrant patients consulting for the first time for HIV infection

E. Rouveix, C. Dupont, E. Mortier, 2005, AIDS care.

The Predictive Value of Head Circumference Growth during the First Year of Life on Early Child Traits

G. Muckle, W. Fraser, J. Séguin, 2018, Scientific Reports.

[Aging and HIV infection: 4 years follow-up of 149 HIV infected patients older than 60 years in West Paris agglomeration (COREVIH Île-de-France Ouest)].

P. de Truchis, D. Zucman, E. Rouveix, 2013, Presse medicale.

Pneumocystis carinii Pneumonia Recurrence in HIV Patients on Highly Active Antiretroviral Therapy: Secondary Prophylaxis

D. Costagliola, S. Abgrall, S. Matheron, 2001, Journal of acquired immune deficiency syndromes.